Tag archive for ‘Redhill Biopharma’

Israel’s RedHill Biopharma To Expand Experimental COVID-19 Treatment Opaganib

RedHill Biopharma, an Israeli bio-medical firm, has announced collaborations with two specialist pharmaceutical manufacturers in Europe and Canada to ramp-up manufacturing of Opaganib, a new Covid-19 treatment More...

new Cystic Fibrosis treatment
Gil Tanenbaum On Wednesday, January 18th, 2017

Possible Cystic Fibrosis Treatment — Disease Prevalent Among Ashkenazic Jews

A new treatment for Cystic Fibrosis may have been developed by researchers in New Zealand. The disease affects a disproportionate number of Ashkenazic Jews. A study titled “Biological Function of a Polysaccharide More...

Jewish Business News On Monday, February 8th, 2016

RedHill Biopharma Collaborates with Germany’s Fraunhofer Institute for Oncology Drug RP101

RedHill Biopharma Ltd., an Israeli biopharmaceutical company today announced a research collaboration with Leipzig-based Fraunhofer Institute for Cell Therapy and Immunology (IZI), a research unit of the More...

Ilan Shavit On Wednesday, October 9th, 2013

Redhill Biopharma Seeks Meeting With FDA For Extended Release Anti-emetic Drug Formulation

– RedHill Biopharma Ltd. (Redhill) reported positive pharmacokinetic (PK) clinical studies for their planned new drug application (NDA) for their RHB-102 extended release Anti-Emetic product. RedHill More...

Wordpress site Developed by Fixing WordPress Problems